Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Cadsys India IPO and Vanta Bioscience IPO.
Cadsys India IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Vanta Bioscience IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Cadsys India IPO | Vanta Bioscience IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Saffron Capital Advisors Private Limited | Inventure Merchant Banker Services Pvt Ltd |
| Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Cadsys India IPO is up to ₹14.70 Cr whereas the issue size of the Vanta Bioscience IPO is up to ₹7.56 Cr. The final issue price of Cadsys India IPO is ₹70.00 per share and of Vanta Bioscience IPO is ₹50.00 per share.
| Cadsys India IPO | Vanta Bioscience IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹70.00 per share | ₹50.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 21,00,000 shares | 15,12,000 shares |
| Issue Size Total (Amount) | up to ₹14.70 Cr | up to ₹7.56 Cr |
Cadsys India IPO opens on Sep 21, 2017, while Vanta Bioscience IPO opens on Sep 25, 2017. The closing date of Cadsys India IPO and Vanta Bioscience IPO is Sep 25, 2017, and Sep 27, 2017, respectively.
| Cadsys India IPO | Vanta Bioscience IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 21, 2017 | Sep 25, 2017 |
| Issue Close | Sep 25, 2017 | Sep 27, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Cadsys India IPO P/E ratio is , as compared to Vanta Bioscience IPO P/E ratio of .
| Cadsys India IPO | Vanta Bioscience IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Cadsys India IPO retail investors (RII) are offered while in Vanta Bioscience IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Cadsys India IPO and in Vanta Bioscience IPO.
| Cadsys India IPO | Vanta Bioscience IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Cadsys India IPO subscribed in total, whereas Vanta Bioscience IPO subscribed .
| Cadsys India IPO | Vanta Bioscience IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
